SCHEMBL4352578

SCHEMBL4352578

O=C1N=C(N2CCSCC2)S/C1=C\c1ccccc1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.80
DCTPP1 Q9H773 1/20 0.64
MAPT P10636 6/20 0.60
RAB9A P51151 4/20 0.59
AVPR1A P37288 1/20 0.58
KMT2A Q03164 7/20 0.58
HTT P42858 2/20 0.58
GRIN1 Q05586 2/20 0.58
GRIN2B Q13224 2/20 0.58
NPC1 O15118 4/20 0.57
MEN1 O00255 6/20 0.56
MAPK1 P28482 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
HPGD P15428 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
ALOX5 P09917 1/20 0.55
IDE P14735 1/20 0.55
CYP1A2 P05177 1/20 0.54
CYP2C19 P33261 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4352583 1.00 ALDH1A1 (0.80) ALDH1A1DCTPP1MAPTRAB9AAVPR1A
SCHEMBL4354199 0.89 ALDH1A1 (1.00) ALDH1A1DCTPP1MAPTRAB9AAVPR1A
SCHEMBL4354203 0.89 ALDH1A1 (1.00) ALDH1A1DCTPP1MAPTRAB9AAVPR1A
Bromide SCHEMBL4346488 0.87 ALDH1A1 (0.97) ALDH1A1DCTPP1MAPTRAB9AAVPR1A
Bromide SCHEMBL4346491 0.87 ALDH1A1 (0.97) ALDH1A1DCTPP1MAPTRAB9AAVPR1A
SCHEMBL4351505 0.86 MAPT (0.81) ALDH1A1DCTPP1MAPTRAB9AKMT2A
SCHEMBL4351510 0.86 MAPT (0.81) ALDH1A1DCTPP1MAPTRAB9AKMT2A
SCHEMBL4355588 0.86 MAPT (0.61) ALDH1A1DCTPP1MAPTRAB9AKMT2A
SCHEMBL4352805 0.86 ENPP2 (0.70) ALDH1A1DCTPP1MAPTRAB9AAVPR1A
SCHEMBL4352806 0.86 ENPP2 (0.70) ALDH1A1DCTPP1MAPTRAB9AAVPR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs ABCB1, ABCG2, SLC5A2 ALDH1A1 284/4885DCTPP1 167/4885MAPT 1470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.